PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Paul Rennie interviewed on Marcus Today Podcast., page-30

  1. 478 Posts.
    lightbulb Created with Sketch. 130
    we're all concentrating on the FDA but the TGA might be the dark horse it's an Australian company and they were the first to give it an SAS approval
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.